查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463779

礼宾医疗的全球市场：市场规模和份额分析（按应用（初级保健、儿科、脊椎按摩疗法、内科、心臟病学、精神病学）、所有权类型（单一、团体）、最终用户（成人、儿科）） 、产业需求预测（~2030）

Concierge Medicine Market Size and Share Analysis by Application (Primary Care, Pediatrics, Osteopathy, Internal Medicine, Cardiology, Psychiatry), Ownership (Independent, Group), End User (Adults, Children) - Global Industry Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 310 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场概况

全球特约医疗市场规模约171亿美元。 然而，到 2030 年，这一数字预计将增加至 276 亿美元，2024 年至 2030 年的复合年增长率为 7.3%。

该行业的发展得益于早期疾病诊断知识的增加、老年人口的增加以及个人为实现健康平衡的生活方式而付出的不断努力。 此外，特约医疗提供的好处包括医生的薪酬更高和患者的等待时间更短。

关键见解

到2023年，初级保健类别将占据最大的产业份额。 这是由于病患意识的提高、立即就医和先进的医疗服务。

由于个人化医疗服务和医疗服务提供者的短缺，礼宾医疗保健在高收入人群中越来越受欢迎。

预计儿科在预测期内的复合年增长率最高为 7.8%。 这是因为儿科医生有更多的时间来治疗个别患者，特别是需要针对性诊断和治疗的新生儿、婴幼儿。

到 2023 年，团体类别将以约 60% 的份额主导产业。

预计在预测期内，礼宾医学的单一管理（从业者）将迅速发展。

在本报告中，我们分析了全球特约医疗市场，包括市场的基本结构、最新情况、主要推动和限制因素以及全球、按地区和主要国家的市场规模前景（以货币形式计算，2017 -2030），按用途、所有权类型和最终用户划分的详细趋势、当前市场竞争状况以及主要公司概况。

目录

第1章研究范围

第2章研究方法

第 3 章执行摘要

第 4 章市场指标

第4章产业展望

  • 市场动态
    • 趋势
    • 促进因素
    • 抑制因素/挑战
    • 促进/抑制因子影响分析
  • 新型冠状病毒感染 (COVID-19) 的影响
  • 波特五力分析

第6章世界市场

  • 摘要
  • 市场收入：依应用分类（2017-2030 年）
  • 市场收入：依所有权类型划分（2017-2030 年）
  • 市场收入：以最终用户划分（2017-2030 年）
  • 市场收入：按地区划分（2017-2030 年）

第7章北美市场

  • 摘要
  • 市场收入：依应用分类（2017-2030 年）
  • 市场收入：依所有权类型划分（2017-2030 年）
  • 市场收入：以最终用户划分（2017-2030 年）
  • 市场收入：依国家/地区划分（2017-2030 年）

第8章欧洲市场

第9章亚太市场

第10章拉丁美洲市场

第11章中东及非洲市场

第12章美国市场

  • 摘要
  • 市场收入：依应用分类（2017-2030 年）
  • 市场收入：依所有权结构划分（2017-2030 年）
  • 市场收入：以最终用户划分（2017-2030 年）

第13章加拿大市场

第14章德国市场

第15章法国市场

第16章英国市场

第17章义大利市场

第18章西班牙市场

第19章日本市场

第20章中国市场

第21章印度市场

第22章澳洲市场

第23章韩国市场

第24章巴西市场

第25章墨西哥市场

第26章沙乌地阿拉伯市场

第27章南非市场

第 28 章阿联酋 (UAE) 市场

第29章竞争态势

  • 市场参与者及其提供的产品/服务的列表
  • 主要公司的竞争基准
  • 各大公司的产品基准
  • 近期策略发展状况

第30章公司简介

  • Campbell Family Medicine
  • Castle Connolly Private Health Partners LLC
  • CONCIERGE CONSULTANTS & CARDIOLOGY
  • MDVIP LLC
  • PartnerMD
  • PENINSULA DOCTOR
  • Priority Physicians Inc.
  • SignatureMD Inc.
  • Specialdocs Consultants LLC

第31章 附录

简介目录
Product Code: 12826

Market Overview

The global concierge medicine market is around USD 17.1 billion. However, this figure is estimated to rise to USD 27.6 billion by 2030, which is equivalent to a 7.3% compound annual growth rate from 2024 to 2030.

This development of the industry can be credited to the increasing knowledge about initial disease diagnosis, the growing elderly populace, and the increasing efforts of individuals to attain a healthy and balanced lifestyle. Moreover, the benefits provided by concierge medicine comprise high recompenses for doctors and reduced waiting times for patients, which make this method common among both.

With the increasing use of telemedicine and tele health, the market picked up. Patients who have availed of concierge medicine services appreciate these technologies as they can schedule consultations with the physician as and when convenient. On the other hand, it replaces traveling that a patient would take to the doctor 's office.

This helps save patients time and money. Telemedicine applications provide high-resolution audio and video teleconferences, which enable easy access for patients to the physician from the comfort of their homes.

In addition to that, providers can manage the number of patients not showing up, since telemedicine could be utilized for this purpose. Thus, the convenience offered by such technologies has a positive impact on patient flow and increases the doctor's revenue.

Key Insights

In 2023, the primary care category grips the largest industry share because of augmented patient awareness, offering instant access to doctors and advanced-quality medicinal services.

For the patients the main advantage of primary care is that they receive longer, more comprehensive consultations, and get used to this setting, with the high patient volumes, to keep pace.

Concierge medicine is gaining popularity among high earners due to personalized healthcare services and the shortage of healthcare providers.

Paediatrics is projected to have the highest CAGR rate of 7.8% during the forecast period because pediatricians will have more time to treat each patient, especially neonates, infants, and toddlers who require targeted diagnosis and treatment.

In 2023, the group category dominates the industry with a share of approximately 60%.

The substantial existence of several top firms in the market offering these services is the major factor propelling the market.

Independent ownership in concierge medication is projected to advance quickly over the forecast period.

Independent practitioners see fewer patients every day in comparison to regular and group ownership models, leading to less workload, better compensation, and job satisfaction.

Rising awareness regarding physical well-being and the accuracy of healthcare boosts industry development.

Well-established healthcare infrastructure and favourable medical reimbursement policies contribute significantly to the region's dominance.

The global increase in the range of diseases of duration such as cancer, hyperglycaemia, and obesity is an issue that facilitates the development of precision medicine solutions.

The presence of a significant elderly population drives demand for immediate medical attention, supporting market growth.

The customization healthcare services, come with convenience and personalized care, thus attracting elderly patients and leading to the broadening of the market.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by application
    • 1.4.2. Market size breakdown, by ownership
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Application (2017-2030)
  • 6.3. Market Revenue, by Ownership (2017-2030)
  • 6.4. Market Revenue, by End User (2017-2030)
  • 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Application (2017-2030)
  • 7.3. Market Revenue, by Ownership (2017-2030)
  • 7.4. Market Revenue, by End User (2017-2030)
  • 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Application (2017-2030)
  • 8.3. Market Revenue, by Ownership (2017-2030)
  • 8.4. Market Revenue, by End User (2017-2030)
  • 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Application (2017-2030)
  • 9.3. Market Revenue, by Ownership (2017-2030)
  • 9.4. Market Revenue, by End User (2017-2030)
  • 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Application (2017-2030)
  • 10.3. Market Revenue, by Ownership (2017-2030)
  • 10.4. Market Revenue, by End User (2017-2030)
  • 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Application (2017-2030)
  • 11.3. Market Revenue, by Ownership (2017-2030)
  • 11.4. Market Revenue, by End User (2017-2030)
  • 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Application (2017-2030)
  • 12.3. Market Revenue, by Ownership (2017-2030)
  • 12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Application (2017-2030)
  • 13.3. Market Revenue, by Ownership (2017-2030)
  • 13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Application (2017-2030)
  • 14.3. Market Revenue, by Ownership (2017-2030)
  • 14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Application (2017-2030)
  • 15.3. Market Revenue, by Ownership (2017-2030)
  • 15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Application (2017-2030)
  • 16.3. Market Revenue, by Ownership (2017-2030)
  • 16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Application (2017-2030)
  • 17.3. Market Revenue, by Ownership (2017-2030)
  • 17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Application (2017-2030)
  • 18.3. Market Revenue, by Ownership (2017-2030)
  • 18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Application (2017-2030)
  • 19.3. Market Revenue, by Ownership (2017-2030)
  • 19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Application (2017-2030)
  • 20.3. Market Revenue, by Ownership (2017-2030)
  • 20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Application (2017-2030)
  • 21.3. Market Revenue, by Ownership (2017-2030)
  • 21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Application (2017-2030)
  • 22.3. Market Revenue, by Ownership (2017-2030)
  • 22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Application (2017-2030)
  • 23.3. Market Revenue, by Ownership (2017-2030)
  • 23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Application (2017-2030)
  • 24.3. Market Revenue, by Ownership (2017-2030)
  • 24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Application (2017-2030)
  • 25.3. Market Revenue, by Ownership (2017-2030)
  • 25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Application (2017-2030)
  • 26.3. Market Revenue, by Ownership (2017-2030)
  • 26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Application (2017-2030)
  • 27.3. Market Revenue, by Ownership (2017-2030)
  • 27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Application (2017-2030)
  • 28.3. Market Revenue, by Ownership (2017-2030)
  • 28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Campbell Family Medicine
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Castle Connolly Private Health Partners LLC
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. CONCIERGE CONSULTANTS & CARDIOLOGY
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. MDVIP LLC
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. PartnerMD
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. PENINSULA DOCTOR
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Priority Physicians Inc.
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. SignatureMD Inc.
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Specialdocs Consultants LLC
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports